Brainomix specialises in the creation of AI-powered imaging biomarkers to enable precision medicine for better treatment decisions.
They launched in 2010 when they spun out of the University of Oxford.
They have developed awards-winning AI-powered imaging biomarkers and software solutions, assisting physicians across the world to make better life-saving decisions.
- 25+ countries
- 50+ clinical publications
- A patient scanned every 5 minutes
- Results available in 1 minute
Their expert team of clinicians, stroke neurologists, scientists, business professionals and engineers have the necessary insight and experience to confidently serve the world’s most demanding clinical communities.
The most comprehensive stroke imaging solution
e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providing a real-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.
Their proprietary software can uniquely generate critical information from simple brain scans that can help expand patient access to life-saving stroke treatments.
Their AI-powered advanced technology has been studied in a number of publications, providing technical validation and demonstrating health economic benefit, and has also been shown to improve stroke treatment rates, both thrombectomy and thrombolysis.
The e-Stroke Cloud is a service designed to optimize workflow across stroke networks by enabling access to pseudonymized scan results from anywhere, including on the e-Stroke Mobile app, a tool enabling clinicians to have quick, easy access to critical results, strengthening the connection between clinicians, facilitating faster treatment decisions.
Supported web browsers include IE 11, and current versions of Edge, Firefox, Chrome and iPad Safari. e-Stroke Mobile is compatible with both Android and iOS devices.
Brainomix and NCIMI
“Our partnership with NCIMI has been instrumental in helping to accelerate the adoption of our software across the extended Thames Valley regional stroke network, empowering clinicians to make faster, more confident treatment decisions, ultimately improving patient care.”
Dr Michalis Papadakis, CEO & Co-Founder, Brainomix
To learn more about Brainomix please visit their website.
For more information, please contact firstname.lastname@example.org